Holen Sie sich die Stockscreener-App
90.54
2.95%
-2.75
Handel nachbörslich:
90.54
Schlusskurs vom Vortag:
$93.29
Offen:
$93.41
24-Stunden-Volumen:
1.49M
Relative Volume:
0.90
Marktkapitalisierung:
$12.12B
Einnahmen:
$2.51B
Nettoeinkommen (Verlust:
$185.56M
KGV:
67.57
EPS:
1.34
Netto-Cashflow:
$517.59M
1W Leistung:
+3.70%
1M Leistung:
-0.61%
6M Leistung:
+61.77%
1J Leistung:
+8.50%
1-Tages-Spanne:
$90.01
$93.90
1-Wochen-Bereich:
$85.65
$93.90
52-Wochen-Spanne:
$51.79
$94.93
Globus Medical Inc Stock (GMED) Company Profile
Firmenname
Globus Medical Inc
Sektor
Branche
Telefon
610-930-1800
Adresse
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Vergleichen Sie GMED mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
90.54 | 12.49B | 2.51B | 185.56M | 517.59M | 1.34 |
|
ABT
Abbott Laboratories
|
127.04 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.67 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.75 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.76 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.85 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-07 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-11-07 | Hochstufung | Truist | Hold → Buy |
| 2025-10-28 | Fortgesetzt | Stifel | Hold |
| 2025-05-27 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-01-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-07 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-09-19 | Hochstufung | Stifel | Hold → Buy |
| 2023-03-30 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-02-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-02-10 | Herabstufung | Loop Capital | Buy → Hold |
| 2023-02-10 | Herabstufung | Needham | Buy → Hold |
| 2023-02-10 | Herabstufung | Truist | Buy → Hold |
| 2023-02-10 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-28 | Eingeleitet | Wells Fargo | Overweight |
| 2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | Hochstufung | BofA Securities | Underperform → Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-10-29 | Eingeleitet | Loop Capital | Buy |
| 2021-02-18 | Fortgesetzt | Needham | Buy |
| 2020-12-08 | Eingeleitet | Citigroup | Buy |
| 2020-10-20 | Eingeleitet | Stifel | Hold |
| 2020-08-06 | Bestätigt | Needham | Buy |
| 2020-08-06 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | Eingeleitet | Northland Capital | Market Perform |
| 2020-07-06 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | Bestätigt | Needham | Buy |
| 2020-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-12-12 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | Bestätigt | Needham | Buy |
| 2019-05-24 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | Bestätigt | Needham | Buy |
| 2019-02-28 | Hochstufung | UBS | Neutral → Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-27 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-05-03 | Bestätigt | Needham | Buy |
| 2018-04-04 | Hochstufung | Needham | Hold → Buy |
Alle ansehen
Globus Medical Inc Aktie (GMED) Neueste Nachrichten
Stifel raises Globus Medical stock price target to $90 on strong outlook - Investing.com UK
Will Globus Medical Inc. stock attract ESG investors2026 world cup usa national team qualification top scorers counter attacking winner prediction tactical review - ulpravda.ru
Does Globus Medical (NYSE:GMED) Deserve A Spot On Your Watchlist? - Yahoo Finance
Allspring Global Investments Holdings LLC Acquires 312,149 Shares of Globus Medical, Inc. $GMED - MarketBeat
Globus Medical (NYSE:GMED) Rating Increased to Strong-Buy at Wall Street Zen - MarketBeat
Globus Medical Inc: The Spine Stock Wall Street Slept On (Until Now) - AD HOC NEWS
Globus Medical (GMED) Lags Q1 Earnings and Revenue Estimates - sharewise.com
The Truth About Globus Medical Inc: Why Wall Street Suddenly Can’t Ignore It - AD HOC NEWS
Fort Washington Investment Advisors Inc. OH Raises Holdings in Globus Medical, Inc. $GMED - MarketBeat
Globus Medical (NYSE:GMED) Listed in NYSE Composite Healthcare Group - Kalkine Media
Should I hold or sell Globus Medical Inc. stock in 2025Debt-to-Equity Ratio Analysis & Free High Yield Investment Strategies - bollywoodhelpline.com
Globus Medical, Inc. $GMED is Paradice Investment Management LLC's Largest Position - MarketBeat
BTIG reiterates Neutral rating on Globus Medical stock after strong Q3 - Investing.com Canada
Audubon’s Globus Medical Makes Game-Changing Acquisition - MSN
Boston Trust Walden Corp Takes $67.89 Million Position in Globus Medical, Inc. $GMED - MarketBeat
Globus Medical, Inc. (NYSE:GMED) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Globus Medical, Inc. Class A Common Stock (NYSE:GMED) Stock Quote - FinancialContent
Swedbank AB Increases Position in Globus Medical, Inc. $GMED - MarketBeat
Globus Medical (GMED): Assessing Valuation After a 60% Three-Month Share Price Surge - Sahm
Globus Medical (STU:GM0N) EV-to-OCF : 15.30 (As of Dec. 24, 2025) - GuruFocus
Globus Medical Earnings Notes - Trefis
Here's Why Globus Medical (GMED) is a Strong Growth Stock - sharewise.com
Exchange Traded Concepts LLC Has $13.41 Million Stake in Globus Medical, Inc. $GMED - MarketBeat
Globus Medical (GMED) Stock Trades Up, Here Is Why - Finviz
Globus Medical (GMED) Gains as Analysts Raise Price Targets in Late 2025News and Statistics - IndexBox
Profit Investment Management LLC Has $1.09 Million Holdings in Globus Medical, Inc. $GMED - MarketBeat
Why Globus Medical (GMED) is a top growth stock for the long term - MSN
How Investors May Respond To Globus Medical (GMED) Analyst Optimism Around Clinical Trial Momentum - Sahm
Is Globus Medical Inc. Class stock undervalued historicallyEarnings Risk Report & Growth Focused Entry Reports - ulpravda.ru
Precision Trading with Globus Medical Inc. Class A (GMED) Risk Zones - Stock Traders Daily
Will Globus Medical Inc. stock benefit from upcoming earnings reportsMarket Sentiment Report & Precise Trade Entry Recommendations - ulpravda.ru
Can Globus Medical Inc. stock continue upward trend2025 Key Lessons & Smart Money Movement Alerts - DonanımHaber
Is Globus Medical Still Attractive After Recent Gains and DCF Implied Upside? - Yahoo Finance
Why Globus Medical Inc. stock could benefit from AI revolutionTrade Performance Summary & Step-by-Step Trade Execution Guides - DonanımHaber
Globus Medical (GMED): Reassessing Valuation After a 55% Three-Month Share Price Surge - Yahoo Finance
Is Globus Medical Inc. stock dividend yield sustainablePortfolio Performance Report & Accurate Entry and Exit Point Alerts - DonanımHaber
What is the fair value of Globus Medical Inc. stock nowBear Alert & Free Reliable Trade Execution Plans - Улправда
Globus Medical (GMED) Stock Up on RBC Target Boost & Trial NewsNews and Statistics - IndexBox
Analysts Offer Insights on Healthcare Companies: Novan (NOVN) and Globus Medical (GMED) - The Globe and Mail
RBC Capital Maintains Globus Medical (GMED) Outperform Recommendation - Nasdaq
Freedom Capital Markets Initiates Coverage of Globus Medical (GMED) with Hold Recommendation - Nasdaq
Canaccord Genuity Maintains Globus Medical (GMED) Buy Recommendation - Nasdaq
GMED Stock: Analyst Raises Price Target to $105, Maintains Buy R - GuruFocus
Analyst Upgrade: How buybacks impact Globus Medical Inc stock value2025 Volume Leaders & AI Powered Market Trend Analysis - moha.gov.vn
RBC Adjusts Price Target on Globus Medical to $100 From $92, Maintains Outperform Rating - marketscreener.com
RBC Capital Raises Price Target for GMED to $100, Maintains Outp - GuruFocus
Pedicle Screw Systems Market Size to Hit USD 3.71 Billion by 2033, Growing at a CAGR of 5.76% - GlobeNewswire Inc.
Thrivent Financial for Lutherans Reduces Holdings in Globus Medical, Inc. $GMED - MarketBeat
Globus Medical Director Sells 4,000 Shares - TradingView — Track All Markets
Dir Norwalk Sells 4,000 ($355.4K) Of Globus Medical Inc [GMED] - TradingView — Track All Markets
Globus Medical (NYSE: GMED) director reports 4,000-share sale at $88.85 - Stock Titan
Finanzdaten der Globus Medical Inc-Aktie (GMED)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.20%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):